Literature DB >> 27739308

Critical Role of the Secondary Binding Pocket in Modulating the Enzymatic Activity of DUSP5 toward Phosphorylated ERKs.

Marat R Talipov1, Jaladhi Nayak2, Michael Lepley2, Robert D Bongard3, Daniel S Sem3, Ramani Ramchandran2, Rajendra Rathore1.   

Abstract

DUSP5 is an inducible nuclear dual-specificity phosphatase that specifically interacts with and deactivates extracellular signal-regulated kinases ERK1 and ERK2, which are responsible for cell proliferation, differentiation, and survival. The phosphatase domain (PD) of DUSP5 has unique structural features absent from other nuclear DUSPs, such as the presence of a secondary anion-binding site in the proximity of the reaction center and a glutamic acid E264 positioned next to the catalytic cysteine C263, as well as a remote intramolecular disulfide linkage. The overall 400 ns molecular dynamics simulations indicate that the secondary binding site of DUSP5 PD acts as an allosteric regulator of the phosphatase activity of DUSP5. Our studies have identified E264 as a critical constituent of the dual binding pocket, which regulates the catalytic activity of DUSP5 by forming a salt bridge with arginine R269. Molecular dynamics studies showed that initial occupation of the secondary binding pocket leads to the breakage of the salt bridge, which then allows the occupation of the active site. Indeed, biochemical analysis using the pERK assay on mutant E264Q demonstrated that mutation of glutamic acid E264 leads to an increase in the DUSP5 catalytic activity. The role of the secondary binding site in assembling the DUSP5-pERK pre-reactive complex was further demonstrated by molecular dynamics simulations that showed that the remote C197-C219 disulfide linkage controls the structure of the secondary binding pocket based on its redox state (i.e., disulfide/dithiol) and, in turn, the enzymatic activity of DUSP5.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27739308     DOI: 10.1021/acs.biochem.6b00498

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  Discovery and Characterization of Halogenated Xanthene Inhibitors of DUSP5 as Potential Photodynamic Therapeutics.

Authors:  Ramani Ramchandran; Daniel S Sem; Robert D Bongard; Michael Lepley; Adam Gastonguay; Raulia R Syrlybaeva; Marat R Talipov; Rachel A Jones Lipinsky; Noah R Leigh; Jaladhi Brahmbhatt; Raman Kutty; Rajendra Rathore
Journal:  J Photochem Photobiol A Chem       Date:  2019-02-10       Impact factor: 4.291

2.  Long non-coding RNA HOXA11-AS promotes the proliferation HCC cells by epigenetically silencing DUSP5.

Authors:  Bin Liu; Jing Li; Xiaoling Liu; Min Zheng; Ye Yang; Qian Lyu; Li Jin
Journal:  Oncotarget       Date:  2017-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.